Patent Assignment Details
NOTE:Results display only for issued patents and published applications.
For pending or abandoned applications please consult USPTO staff.
|
| Reel/Frame: | 059294/0317 | |
| Pages: | 4 |
| | Recorded: | 03/17/2022 | | |
| Attorney Dkt #: | BAYERAG-0264-E |
| Conveyance: | ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). |
|
|
Total properties:
4
|
|
|
|
Patent #:
|
|
Issue Dt:
|
04/09/2024
|
Application #:
|
16617642
|
Filing Dt:
|
11/27/2019
|
|
Publication #:
|
|
Pub Dt:
|
06/11/2020
| | | | |
|
Title:
|
COMBINATION OF REGORAFENIB AND PD-1/PD-L1(2) INHIBITORS FOR TREATING CANCER
|
|
|
|
|
Patent #:
|
NONE
|
Issue Dt:
|
|
Application #:
|
16731409
|
Filing Dt:
|
12/31/2019
|
|
Publication #:
|
|
Pub Dt:
|
05/21/2020
| | | | |
|
Title:
|
COMBINATION OF REGORAFENIB AND PD-1/PD-L1(2) INHIBITORS FOR TREATING CANCER
|
|
|
|
|
Patent #:
|
|
Issue Dt:
|
12/06/2022
|
Application #:
|
16731412
|
Filing Dt:
|
12/31/2019
|
|
Publication #:
|
|
Pub Dt:
|
06/18/2020
| | | | |
|
Title:
|
COMBINATION OF REGORAFENIB AND PD-1/PD-L1(2) INHIBITORS FOR TREATING CANCER
|
|
|
|
|
Patent #:
|
NONE
|
Issue Dt:
|
|
Application #:
|
17576522
|
Filing Dt:
|
01/14/2022
|
|
Publication #:
|
|
Pub Dt:
|
05/05/2022
| | | | |
|
Title:
|
COMBINATION OF REGORAFENIB AND PD-1/PD-L1(2) INHIBITORS FOR TREATING CANCER
|
|
|
Assignee
|
|
|
|
|
| 100 BAYER BOULEVARD |
| WHIPPANY, NEW JERSEY 07981-0915 |
|
|
Correspondence name and address
|
| |
MILLEN, WHITE, ZELANO & BRANIGAN, P.C.,
|
| |
2200 CLARENDON BLVD.
|
| |
SUITE 1400
|
| |
ARLINGTON, VA 22201
|
Search Results as of:
06/21/2024 03:56 AM
If you have any comments or questions concerning the data displayed,
contact
PRD / Assignments at 571-272-3350. v.2.6
Web interface last modified:
August 25, 2017 v.2.6
|
